A prophylactic vaccine for breast cancer?

Breast Cancer Research

Volumn 12, Issue 4, 2010, Pages

  Watson, Christine J ^a   Gusterson, Barry A ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; LACTALBUMIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOUSE;

ANIMALS; BREAST NEOPLASMS; CANCER VACCINES; FEMALE; HUMANS; IMMUNIZATION; LACTALBUMIN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C;

EID: 78650905238     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2628     Document Type: Article

References (9)

1. Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. J Immunol 2008, 181:6955-6963. 2579962, 18981115.
2. Heithoff DM, Enioutina EY, Bareyan D, Daynes RA, Mahan MJ. Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity. Infect Immun 2008, 76:5191-5199. 2573365, 18765736, 10.1128/IAI.00759-08.
3. Carr-Brendel V, Markovic D, Ferrer K, Smith M, Taylor-Papadimitriou J, Cohen EP. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1. Cancer Res 2000, 60:2435-2443.
4. Yuan S, Shi C, Liu L, Han W. MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy. Expert Opin Biol Ther 2010, 10:1037-1048. 10.1517/14712598.2010.485185, 20420512.
5. Baxevanis CN, Voutsas IF, Gritzapis AD, Perez SA, Papamichail M. HER-2/neu as a target for cancer vaccines. Immunotherapy 2010, 2:213-226. 10.2217/imt.09.89, 20635929.
6. Stanley M, Gissmann L, Nardelli-Haefliger D. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines. Vaccine 2008, 26(Suppl 10):K62-K67. 10.1016/j.vaccine.2008.05.066, 18847558.
7. Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 2010, 16:799-803. 10.1038/nm.2161, 20512124.
8. Hall L, Craig RK, Davies MS, Ralphs DNL, Campbell PN. α-Lactalbumin is not a marker of human hormone-dependent breast cancer. Nature 1981, 290:602-604. 10.1038/290602a0, 7219546.
9. Bailey AJ, Sloane JP, Trickey BS, Ormerod MG. An immunocytochemical study of α-lactalbumin in human breast tissue. J Pathol 1982, 137:13-23. 10.1002/path.1711370103, 7045307.